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Objective: to determine whether serum elastin-derived peptides (S-EDP), are lower in patients with ruptured abdominal
aortic aneurysms (rAAA) than asymptomatic (aAAA).
Materials and methods: serum samples were collected preoperatively from 45 consecutive patients with aAAA and 15
haemodynamically stable patients with rAAA. S-EDP (ng/ml) was measured by a competitive enzyme-linked im-
munosorbent assay (ELISA).
Results: S-EDP (mean±s.d.) was significantly lower in patients with rAAA (31.6 ng/ml±6.8) than in patients with
aAAA (39.4 ng/ml±8.0; p=0.001).
Conclusion: patients with rAAA had significantly lower levels of S-EDP than patients with aAAA. The possibility that
S-EDP can be used to identify patients at increased risk of rupture requires further investigation.
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Introduction Materials
Elastin is the principal load-bearing element in the Forty-five consecutive patients having elective repair
of an aAAA and 15 haemodynamically stable rAAAnormal aorta.1 Degradation of elastin is a key event
in the development of abdominal aortic aneurysms patients with contained ruptures, were studied. None
of the patients had been operated on the previous 6(AAA)2 and is significantly increased in AAA tissue
compared to normal aorta.3 A chronic inflammatory months and none had received more than 1 l of crys-
talloid in the 24 h prior to AAA surgery. Haematocritinfiltrate4 is a major source of proteolytic enzymes,
such as serine elastases5 and metalloproteinases,3,6–8 was measured and a serum sample was collected
preoperatively. All serum samples were immediatelywhich is participating in the elastolytic process in the
AAA wall. The concentration of elastin is reduced frozen at −70 °C. Retrospective data of current smok-
ing, diagnosis of hypertension and COPD were ob-in the wall of asymptomatic AAA (aAAA),9,10 and
particularly in ruptured rAAA.11,12 tained. The maximal cross-sectional AAA diameters
were measured preoperatively by CT scan and/orThe degradation products of elastin, elastin-derived
peptides (EDP), are hydrophilic and enter the blood- sonography. In two cases of rAAA the diameter
measurement was performed peroperatively. Allstream.13 Serum levels of EDP (S-EDP) can be measured
by a competitive enzyme-linked immunosorbent assay patients gave informed consent. The study was ap-
proved by the Scientific Ethics Committee, Umea˚ Uni-(ELISA).14–17 In AAA disease, S-EDP may predict ex-
pansion of small (<5 cm in diameter) AAA.18 versity Hospital and reported to the Central Control
of Registers.As a consequence of relatively lower concentrations
of elastin in rAAA compared to aAAA, the aim of this
study was to determine whether S-EDP levels are
Methodslower in patients with rAAA than in patients with
aAAA.
Preparation of antibodies
To obtain soluble alpha-elastin, insoluble elastin from∗ Please address all correspondence to: E. Petersen, Department of
Surgery, Umea˚ University Hospital, S-901 85 Umea˚ Sweden. bovine neck ligament was treated with 0.25 M oxalic
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acid at 90 °C.19 The alpha-elastin was dissolved in correlation coefficient were used. Statistical sig-
nificance was set at 95% (p<0.05). Results were reportedphosphate buffer saline (PBS) to a concentration of
2 mg/ml, followed by emulsion in an equal volume as means±standard deviation (s.d.).
of Freund’s complete adjuvant. New Zealand White
rabbits were immunised by multiple subcutaneous
injections using complete Freund’s adjuvant. All of the
Resultsrabbits were boostered fortnightly over a period of 3
months. The rabbits were bled by ear venous puncture
Characteristics of the patients with aAAA and rAAA10 days after the last injection, and serum was collected
are given in Table 2. The level of S-EDP (mean±s.d.)by centrifugation. Immunoglobulins were purified
was significantly lower in patients with rAAAusing protein-A affinity chromatography and dialysed
(31.6 ng/ml±6.8) than in patients with aAAAagainst PBS and stored in a concentration of 2 mg/ml
(39.4±8.0 ng/ml, p=0.001). The significant differenceat 4 °C.
in S-EDP between rAAA and aAAA persisted in a
multiple regression analysis adjusting for age, gender,
Competitive ELISA a diagnosis of COPD and haematocrit (Table 3). There
was a significantly positive correlation between S-The wells on the microtitre plate (Nunc, MaxSorp, EDP and diameter in patients with rAAA (r=0.809,Denmark) were coated with 1250 ng/ml (100 l/well)
p<0.001), but not in patients with aAAA (r=0.034, p=of alpha-elastin peptides in 0.1 M carbonate (pH 9) 0.825).and incubated for 12 h at 4 °C. For standard curve The correlation between aneurysm diameter andgeneration, primary anti alpha-elastin antibody S-EDP levels in patients with aAAA and rAAA is2000 ng/ml in PBS containing 0.05% Tween 20 (PBST) illustrated in Figure 1. The levels of S-EDP in patientsand 7% bovine serum albumin (BSA) were pre-in- with rAAA are scattered in the lower range of thecubated with variable concentrations of alpha-elastin levels in patients with aAAA.peptides from 2.5 to 120 ng/ml for 36 h at 4 °C. Sim-
ultaneously 650 l of non-diluted serum were mixed
with 650 l of anti alpha-elastin antibodies at a con-
centration of 2000 ng/ml and incubated for 36 h at Discussion
4 °C. Two hundred l of each of these reaction mixtures
was transferred to the microtitre plate, which had been No previous investigation has, to our knowledge, com-
coated with alpha-elastin peptides and washed with pared S-EDP levels in patients with aAAA and rAAA.
PBST. The plate was incubated for 1 h at room tem- The present study shows that S-EDP levels are sig-
perature. The wells were then washed with PBST nificantly lower in patients with rAAA than in patients
and 200 l of peroxidase-labelled goat anti-rabbit IgG with aAAA. This may be a consequence of the extreme
antibody (Dako A/S, Denmark), 1:2000 dilution, was depletion of elastin in the wall of rAAA. Less EDP
added. The plate was incubated again for 1 h at room may be produced by degradation of mature elastin in
temperature and washed with PBST. Two hundred l rAAA, since the elastin concentration is relatively
of 0.1 M citrate buffer (pH 4.5), containing 2 mg/ml lower in the rAAA wall compared to the aAAA wall.
of o-phenylene diamine and 0.006% H2O2 were added It may be argued, that low levels of S-EDP in patients
to the plate. After 60 min, the absorbance values were with rAAA could be due to haemodilution. However,
registered at 550 nm using an automatic plate reader only haemodynamically stable rAAA patients with
(Thermomax, Molecular Devices, U.S.A.). minor haemorrhage were studied and there was no
The serum samples were analysed triplicate on at significant difference in haematocrit between aAAA
least two different days and an average of the three and rAAA. Certain aAAA may be more prone to
analyses was calculated. The reproducibility and sensi- rupture and share the characteristics of rAAA leading
tivity of the ELISA are given in Table 1. The anti-alpha- to an overlap in S-EDP levels between the two groups.
elastin antibody recognises human elastin peptides. S-EDP levels depend on the total amount of elastin
in the body exposed to degradation. In healthy tissues
degradation is low. Elastin is an extremely stableStatistical methods
molecule having a half-life of several decades.20,21 In
disease states, such as COPD, elastin degradation inThe statistical program SPSS for Windows 10.0 was
used. S-EDP values were normally distributed. Stu- the lungs is increased and elevated S-EDP levels have
been measured these patients.16,17,22 In the present studydent’s t-test, multiple regression analysis and Pearson
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Table 1. Reproducibility of EDP ELISA.
EDP sensitivity: Within-assay n 12 12 12
precision Mean±s.d. 4.17±1.65 7.17±1.09 20.7±2.28
CV (%) 40 15 11
2.19 ng/ml Between-assay n 4 4 4
precision Mean±s.d. 1.17±0.19 5.80±0.93 17.59±0.96
CV (%) 16 16 5
CV: coefficient of variability.
Table 2. Patient characteristics.
Asymptomatic Ruptured
AAA AAA
n=45 n=15
Age (years) median [range] 67 [52–84] 68 [59–89]
Gender M/F 36/9 13/2
Smoking (n (%)) 16 (36) 5 (33)
COPD (n (%)) 7 (16) 2 (13)
Hypertension (n (%)) 28 (62) 6 (40)
Haematocrit (%), mean±s.d. 38.4±4.0 37.8±3.5
AAA diameter (cm), mean±s.d. 6.6±1.6 6.6±1.2
AAA: abdominal aortic aneurysm. COPD: chronic obstructive pul-
monary disease.
Table 3. Multiple regression analysis with S-EDP (ng/ml) as de-
pendent variable.
Fig. 1. Scatterplot showing the relationship between S-EDP andAll AAAs aneurysm diameter in patients with rAAA and aAAA. For eachn=60 group a regression line is shown. The S-EDP levels in patients with
rAAA are scattered in the lower range of levels in patients withBeta p aAAA. There is a significantly positive correlation between S-EDP
and diameter in patients with rAAA (r=0.809, p<0.001), but notAge (years) −0.047 0.73 in patients with aAAA (r=0.034, p=0.825). S-EDP: serum-elastin-Gender (F/M) −0.048 0.72 derived peptides. aAAA: asymptomatic abdominal aortic aneurysm.Diagnosis of COPD (yes/no) −0.082 0.51 rAAA: ruptured AAA.Haematocrit (%) −0.039 0.76
AAA rupture (yes/no) 0.402 0.003
AAA: abdominal aortic aneurysm. COPD: chronic obstructive pul- diagnosed and untreated hypertension actually con-
monary disease. tributed to the rupture. The low frequency of smokers
in both groups is in contrast with other studies, re-
porting a strong association between smoking and
AAA disease and rupture.26–28 The number of smokerswe did not find any association between S-EDP and
COPD. may be underestimated in this study, as it was based
on patients’ own information.However, it may be due to the surprisingly low
frequency of smokers and COPD. S-EDP levels may It has earlier been reported that S-EDP is a predictor
of expansion of aAAA <5 cm in diameter.18 S-EDPbe influenced by synthesis of new elastin. However,
synthesis of aortic elastin in AAA disease is minimal.23 levels in patients with small aAAA and expansion
rate of the aneurysms may be related to the rate ofIt implies that degradation products of elastin derived
from the AAA wall are mainly degraded original proteolysis in the aneurysm wall. In the early phase of
AAA development, elastin degradation is the principalmature elastin and do not originate from new syn-
thesised elastin. mechanism of reduction in elastin concentration.11 El-
astin is abundant in small AAA and the rate of elastinPatients with contained ruptures may not represent
patients with rAAA in general. There are a 22 percent degradation and EDP production is determined by the
elastolytic rate according to enzyme kinetics. Sincelower frequency of patients with a diagnosis of hyper-
tension in the group of rAAA compared to aAAA, elastin is not synthesized in the adult aorta,23 de-
gradation will gradually decrease the elastin con-although hypertension is associated with increased
risk of rupture.24,25 The reason could be that an un- centration in the AAA wall and even the production
Eur J Vasc Endovasc Surg Vol 22, July 2001
Serum-elastin-derived Peptides in Abdominal Aortic Aneurysm Disease 51
of EDP will theoretically decrease. When destruction serum concentration of the aminoterminal pro-peptide
of type III collagen45 and increased thickness of theof the structural proteins in the AAA wall reaches
intraluminal thrombus.46 Presuming that aneurysmssuch an extent that the wall can not withhold the
prone to rupture have lower elastin concentrations,intraluminal pressure, the aneurysm ruptures. The
S-EDP would be lower in these cases. The presentconcentration of elastin in rAAA seems to be extremely
study may therefore have revealed a possible newlow,11 and according to the kinetics of enzymes will
concept of using S-EDP for identification of AAAthe extreme depletion of elastin cause a low rate of
patients with high risk of rupture.elastin degradation and EDP production, although
In conclusion, patients with rAAA have significantlyelastolytic activity is high in rAAA.29,30 A significant
lower levels of S-EDP than patients with aAAA. Thiscorrelation between S-EDP and diameter of rAAA was
observation may have revealed a possible new conceptobserved in the present study. It is probably due
of identifying patients with increased risk of ruptureto the larger portions of the infrarenal aorta that is
and has to be further investigated.incorporated in the aneurysm with increasing size.
This is followed by an increase of total elastin exposed
to degradation in the aneurysm. No correlation be-
tween S-EDP and aAAA diameter was seen, probably Acknowledgements
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